Companies: 48,874 Total Market Cap: 132455990692658.24

Ind-Swift Laboratories Limited

NSE-INDSWFTLAB
Healthcare Drug Manufacturers - Specialty & Generic
Rank #28996
Market Cap 49.80 M
Volume 296,276
Price 0.84
Change (%) 0.87%
Country or region India India

Ind-Swift Laboratories Limited's latest marketcap:

49.80 M

As of 05/20/2025, Ind-Swift Laboratories Limited's market capitalization has reached $49.80 M. According to our data, Ind-Swift Laboratories Limited is the 28996th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 49.80 M
Revenue (ttm) 54.24 M
Net Income (ttm) 41.43 M
Shares Out 59.09 M
EPS (ttm) 0.70
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/26/2025
Market Cap Chart
Data Updated: 05/20/2025

Ind-Swift Laboratories Limited's yearly market capitalization.

Ind-Swift Laboratories Limited has seen its market value grow from ₹3.68 B to ₹4.26 B since 2020, representing a total increase of 15.69% and an annual compound growth rate (CAGR) of 3.38%.
Date Market Cap Change (%)
05/20/2025 ₹4.26 B -33.66%
12/31/2024 ₹6.42 B 4.85%
12/29/2023 ₹6.12 B 49.1%
12/30/2022 ₹4.10 B 2.21%
12/31/2021 ₹4.01 B 9.16%
12/31/2020 ₹3.68 B

Company Profile

About Ind-Swift Laboratories Limited

Ind-Swift Laboratories Limited, along with its subsidiaries, specializes in the development, manufacturing, and sale of active pharmaceutical ingredients (APIs), intermediates, and formulations. The company operates both in India and internationally, catering to diverse therapeutic needs.

Key Offerings

  • APIs & Intermediates: Covers a wide range of therapeutic areas including macrolide antibiotics, cardiovascular, antidiabetic, antipsychotic, and anticancer treatments.
  • Reference Standards & Impurities: Provides high-quality standards for compounds such as atorvastatin calcium, azithromycin dihydrate, and rosuvastatin calcium.
  • Contract Research & Manufacturing: Offers specialized services for pharmaceutical development and production.

Global Presence

The company exports its products worldwide, ensuring high-quality pharmaceutical solutions reach international markets.

Company Background

Established in 1995, Ind-Swift Laboratories Limited is headquartered in Manimajra, India, and continues to be a trusted name in the pharmaceutical industry.

Frequently Asked Questions

As of 05/20/2025, Ind-Swift Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $49.80 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Ind-Swift Laboratories Limited global market capitalization ranking is approximately 28996 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region India
Founded 1995
IPO Date n/a
Employees 47
CEO
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address Shivalik Enclave
Manimajra, Chandigarh 160101
India
Website https://www.indswiftlabs.com
People Also Watch
Zoetis
163.94 0.87%
Merck KGaA
129.24 0.87%
Haleon plc
542.08 0.87%
NSE-SUNPHARMA
20.23 0.87%